1. Open Versus Minimally Invasive Resection of Gastric GIST: A Multi-Institutional Analysis of Short- and Long-Term Outcomes: A Reply

   • Danielle A. Bischof
   • Timothy M. Pawlik

   Gastrointestinal Oncology 10 November 2017 Pages: 626 - 626

2. Comment on: External Validation of the Simplified Preoperative Assessment for Low-Grade Mucinous Adenocarcinoma of the Appendix

   • Sean P. Dineen
   • Richard E. Royal
   • Keith F. Fournier

   Gastrointestinal Oncology 09 November 2017 Pages: 627 - 627

3. Prognostic Value of Computed Tomography: Measured Parameters of Body Composition in Primary Operable Gastrointestinal Cancers: Methodologic Issues

   • Erfan Ayubi
   • Saeid Safiri

   Gastrointestinal Oncology 16 October 2017 Pages: 628 - 629

4. Comment on: Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study

   • Thales Paulo Batista

   Gynecologic Oncology 01 November 2017 Pages: 630 - 630

5. Survival Analysis in a Randomized Trial of HIPEC in Ovarian Cancer

   • Álvaro Sanz Rubiales
   • María Luisa del Valle

   Gynecologic Oncology 13 October 2017 Pages: 631 - 631

6. Prophylactic “First-Step” Central Neck Dissection (Level 6) Does not Increase Morbidity After (Total) Thyroidectomy

   • Iain J. Nixon

   Head and Neck Oncology 27 October 2017 Pages: 632 - 632

7. In Reply: Prophylactic “First-Step” Central Neck Dissection (Level 6) Does not Increase Morbidity After (Total) Thyroidectomy

   • Andreas Selberherr
   • Philipp Riss
   • Bruno Niederle

   Head and Neck Oncology 27 October 2017 Pages: 633 - 633

8. Partial Verification Distorts Estimates of Sensitivity in Diagnostic Accuracy Studies for Fine-Needle Aspiration Cytology

   • Robert L. Schmid
   • Michael B. Cohen

   Head and Neck Oncology 24 October 2017 Pages: 634 - 636

9. Reply to: Partial Verification Distorts Estimates of Sensitivity in Diagnostic Accuracy Studies for Fine-Needle Aspiration Cytology

   • Dongbin Ahn
   • Ji Yun Jeong

   Head and Neck Oncology 25 October 2017 Pages: 637 - 638

10. Factors Influencing the Decision on Surgery or Observation for Patients with Bethesda Category 3 (AUS/FLUS)

    • Bekir Kuru

    Head and Neck Oncology 30 October 2017 Pages: 639 - 639

11. Microsurgical Reconstruction of the Oral Cavity with Free Flaps from the Anterolateral Thigh and Radial Forearm: Example of Confounding by Indication?

    • S. F. Post
    • P. M. N. Werker
    • P. U. Dijkstra

    Head and Neck Oncology 20 November 2017 Pages: 640 - 640

12. Diffuse Microcalcifications of Only the Thyroid Gland Seen on Ultrasound: Clinical Implication and Diagnostic Approach

    • Eun Ju Ha
    • Jung Hwan Baek
    • Jeong Hyun Lee

    Head and Neck Oncology 30 October 2017 Pages: 641 - 641

13. Yes-Associated Protein (YAP) is a Key Factor for Improving the Management of Cancer Treatments

    • Sushun Liu
    • Jingyao Zhang
    • Chang Liu

    Hepatobiliary Tumors 09 November 2017 Pages: 642 - 643

14. Reply: YAP is a Key Factor to Improve the Management of Cancer Treatments

    • Ping-Li Sun
    • Yan Jin
    • Jin-Haeng Chung

    Hepatobiliary Tumors 14 November 2017 Pages: 644 - 645

15. Port-Site Resection in Surgical Management of Incidental Gallbladder Cancer: A Still Unresolved Question

    • Quanda Liu
    • Naixin Wu
    • Ningxin Zhou

    Hepatobiliary Tumors 20 November 2017 Pages: 646 - 646

16. Port-Site Resection in the Surgical Management of Incidental Gallbladder Cancer: A Still Inconclusive Question: A Reply

    • A. V. Maker
    • W. R. Jarnagin

    Hepatobiliary Tumors 07 November 2017 Pages: 647 - 648

17. Accurate Evaluation of Tumor Necrosis in the Preoperative Period: A New Challenge

    • Ettore Marzano
    • Tullio Piardi
    • Patrick Pessaux

    Hepatobiliary Tumors 30 October 2017 Pages: 649 - 650

    

18. Accurate Evaluation of Tumour Necrosis in the Preoperative Period: A New Challenge: In Reply

    • Meng-Hsing Ho
    • Chung-Bao Hsieh

    Hepatobiliary Tumors 02 November 2017 Pages: 651 - 651

19. Importance of Platelet Indices in Hepatocellular Carcinoma Prognosis

    • Erdim Sertoglu
    • Huseyin Kayadibi
    • Metin Uyanik

    Hepatobiliary Tumors 09 November 2017 Pages: 652 - 652

20. Reply to: Importance of Platelet Indices in Hepatocellular Carcinoma Prognosis

    • Shun-Li Shen
    • Wei Wang
    • Bao-Gang Peng

    Hepatobiliary Tumors 09 November 2017 Pages: 653 - 654

21. Comments to “Long-Term Survival Benefit and Potential for Cure After R1 Resection for Colorectal Liver Metastases”

    • Alessandro Cucchetti
    • Matteo Cescon
    • Giorgio Ercolani

    Hepatobiliary Tumors 16 October 2017 Pages: 655 - 655

22. Comment on “Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases”: A Reply

    • Isamu Hosokawa
    • Marc-Antoine Allard
    • René Adam

    Hepatobiliary Tumors 13 October 2017 Pages: 656 - 657

23. Comment: Detailed Pathologic Examination of Completion Node Dissection Specimens and Outcome for Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases

    • M. F. Madu
    • B. van de Wiel
    • A. C. J. van Akkooi

    Melanomas 07 November 2017 Pages: 658 - 659

24. Reply to comment on: Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases

    • Lodewijka H. J. Holtkamp
    • Shu Wang
    • Richard A. Scolyer

    Melanomas 27 October 2017 Pages: 660 - 660

25. Pre-SN Ultrasound-FNAC can be Sensitive for Lymph Node Metastases in Melanoma Patients if Performed with the Use of the Berlin Criteria

    • Christiane A. Voit
    • Alexander C. J. van Akkooi
    • Alexander M. M. Eggermont

    Melanomas 20 November 2017 Pages: 661 - 662

26. Pre-SN Ultrasound-FNAC for Lymph Node Metastases in Melanoma Patients: A Reply

    • Christy Chai
    • Margaret Szabunio
    • Vernon Sondak

    Melanomas 13 November 2017 Pages: 663 - 664

27. Analysis of 340 Patients with Solid Pseudopapillary Tumors of the Pancreas: A Closer Look at Patients with Metastatic Disease: Methodological Issues

    • Erfan Ayubi
    • Saeid Safiri

    Pancreatic Tumors 16 October 2017 Pages: 665 - 666

28. Reply to “Analysis of 340 Patients with Solid Pseudopapillary Tumors of the Pancreas: A Closer Look at Patients with Metastatic Disease; Methodologic Issues,” by Safiri, Saeid et al.

    • Zeljka Jutric
    • Yelena Rozenfeld
    • Ronald F. Wolf

    Pancreatic Tumors 16 October 2017 Pages: 667 - 668

    

29. Comment on: MicroRNA Expression as a Predictive Marker for Gemcitabine Response After Surgical Resection of Pancreatic Cancer

    • Sameer A. Dhayat
    • Wolf Arif Mardin
    • Norbert Senninger

    Pancreatic Tumors 01 November 2017 Pages: 669 - 669

30. Can Vessel Invasion Change the TNM Stage in Non-small Cell Lung Cancer? A Reply

    • Kazuhito Funai

    Thoracic Oncology 27 November 2017 Pages: 670 - 670

31. Video-Assisted Thoracic Surgery for Patients with Advanced Stage Non-small Cell Lung Cancer

    • Christopher Cao
    • Tristan D. Yan
    • Jianxing He

    Thoracic Oncology 20 November 2017 Pages: 671 - 671

32. Video-Assisted Thoracic Surgery for Patients with Advanced-Stage Non-small Cell Lung Cancer: A Reply

    • Mark Hennon
    • Rohit Sahia
    • Chumy Nwogu

    Thoracic Oncology 27 November 2017 Pages: 672 - 672

33. Similar Significance of Lymphovascular Invasion with Different Treatment Modalities Among Esophageal Squamous Cell Carcinoma

    • Jianhua Fu
    • Hong Yang
    • Kongjia Luo

    Thoracic Oncology 20 October 2017 Pages: 673 - 674

34. EGFR Mutation in Patients with Lung Adenosquamous Cell Carcinoma

    • Tomohiro Tamura
    • Katsunori Kagohashi
    • Hiroaki Satoh

    Thoracic Oncology 03 November 2017 Pages: 675 - 675

35. Reply to “EGFR Mutation in Patients with Lung Adenosquamous Cell Carcinoma”

    • Yosuke Morodomi
    • Tatsuro Okamoto
    • Yoshihiko Maehara

    Thoracic Oncology 27 October 2017 Pages: 676 - 676

36. Age and Charlson Score

    • Michael Froehner
    • Rainer Koch
    • bs Manfred P. Wirth

    Urologic Oncology 28 November 2017 Pages: 677 - 678

37. Age and Charlson Score: A Reply

    • Joo Yong Lee
    • Kang Su Cho

    Urologic Oncology 21 November 2017 Pages: 679 - 679

38. Does Red Blood Cell Distribution Width Really Have a Prognostic Role in Upper Tract Urothelial Carcinoma?

    • Da-xiong Zeng

    Urologic Oncology 06 November 2017 Pages: 680 - 680

39. Comment on: Does Red Blood Cell Distribution Width Really Have a Prognostic Role in Upper Tract Urothelial Carcinoma?

    • Yen-Chen Cheng
    • Ching-Chia Li
    • Hsin-Chih Yeh

    Urologic Oncology 13 November 2017 Pages: 681 - 681

40. Editor Note

    • C. Daniel Johnson
    • Charles M. Balch

    Editor Note 22 January 2016 Pages: 682 - 682

41. Correction to: Reply to ‘‘Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral Versus Bilateral Reconstructions”

    • Ryckie G. Wade
    • Sergio Razzano
    • Andrea Figus

    Correction 20 November 2017 Pages: 683 - 683

42. Erratum to: Trends in Media Reports of Celebrities’ Breast Cancer Treatment Decisions

    • Michael S. Sabel
    • Sonya Dal Cin

    Erratum 13 December 2016 Pages: 684 - 684

43. Erratum to: E1A-Mediated Inhibition of HSPA5 Suppresses Cell Migration and Invasion in Triple-Negative Breast Cancer

    • Hsin-An Chen
    • Yi-Wen Chang
    • Jen-Liang Su

    Erratum 03 February 2017 Pages: 685 - 686

    

44. Erratum to: Impact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic Mastectomy: A Pilot Study

    • Katharine Yao
    • Jeff Belkora
    • Karen Sepucha

    Erratum 27 March 2017 Pages: 687 - 687

45. Erratum to: Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group

    • Trans-Atlantic RPS Working Group

    Erratum 11 May 2017 Pages: 688 - 689

46. Erratum to: Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?

    • Matthew D. Whealon
    • John V. Gahagan
    • Alessio Pigazzi

    Erratum 25 May 2017 Pages: 690 - 690

47. Erratum to: Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer

    • Anita Mamtani
    • Sujata Patil
    • Monica Morrow

    Erratum 17 July 2017 Pages: 691 - 692

    

48. Erratum to: Intraoperative Tumor Detection Using a Ratiometric Activatable Fluorescent Peptide: A First-in-Human Phase 1 Study

    • Jonathan T. Unkart
    • Steven L. Chen
    • Anne M. Wallace

    Erratum 31 July 2017 Pages: 693 - 693

    

49. Erratum to: Predictors of Bowel Function in Long-term Rectal Cancer Survivors with Anastomosis

    • Mubarika Alavi
    • Christopher S. Wendel
    • Lisa J. Herrinton

    Erratum 16 August 2017 Pages: 694 - 694

50. Erratum to: Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy

    • Ryan S. Jackson
    • Parul Sinha
    • Bruce H. Haughey

    Erratum 28 August 2017 Pages: 695 - 695